Sysop: 1 revision imported

2025-11-01T14:15:29Z

1 revision imported

← Older revision	Revision as of 14:15, 1 November 2025
(No difference)

en>Isaak: Common names correctly annotated.

2022-05-13T00:17:22Z

Common names correctly annotated.

New page

{{SubstanceBox


|displayClasses={{{displayClasses|}}}
|MaterialTable_MaxWidth=250px
|MaterialTable_Title={{PAGENAME}}


|ModuleSource=false
|ModuleCombination=false
|ModuleStructure=true
|ModuleNomenclature=true
|ModuleClassMembership=true
|ModuleROA=true


|PhotoImageFile=
|PhotoImageWidth=
|PhotoImageCaption=


|CombinationImage1_Caption=
|CombinationImage1_File=
|CombinationImage1_Width=

|CombinationImage2_Caption=
|CombinationImage2_File=
|CombinationImage2_Width=

|CombinationImage3_Caption=
|CombinationImage3_File=
|CombinationImage3_Width=


|MolecularStructureCaption=The skeletal forumula of sufentanil
|SkeletalImageFile=File:Sufentanil.svg
|SkeletalImageWidth=245px
|3DImageFile=
|3DImageWidth=


|NameCommon=[[common name::Sufentanil]], [[common name::Sufentanyl]], [[common name::Sufenta]], [[common name::Chronogesic]],
|NameSubstitution=
|NameSystematic=N-[4-(Methoxymethyl)-1-(2-thiofuran-2-ylethyl)-4-piperidyl]-N-phenylpropanamide


|EffectClass=[[Psychoactive class::Opioid]]
|ChemicalClass=[[Chemical class::Anilidopiperidine]]



|IntravenousROA=true
|IntravenousROA_Collapsed=false
|IntravenousROA_Caption='''WARNING:''' Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. [[responsible drug use|See responsible use section]]. '''[[Disclaimer|DISCLAIMER]]:''' PW's [[dosage]] information is gathered from users and [[Network|resources]] for educational purposes only. It is not a recommendation. '''This dosage and duration information has been sourced from [http://drugs.tripsit.me/sufentanil TripSit]''' '''Sufentanil can be fatal at heavy doses or if it touches skin. Do not eyeball this drug; [[volumetric liquid dosing]] must be used due to its extreme potency.'''
|IntravenousROA_Bioavailability=
|IntravenousROA_Threshold=[[Intravenous threshold dose::0.1]] [[Intravenous dose units::μg]]
|IntravenousROA_Light=[[Intravenous min light dose::1]] - [[Intravenous max light dose::5]] μg
|IntravenousROA_Common=[[Intravenous min common dose::5]] - [[Intravenous max common dose::10]] μg
|IntravenousROA_Strong=[[Intravenous min strong dose::10]] - [[Intravenous max strong dose::25]] μg
|IntravenousROA_Heavy=[[Intravenous heavy dose::25]] μg +
|IntravenousROA_TimelineFile=
|IntravenousROA_TimelineWidth=
|IntravenousROA_Duration=
|IntravenousROA_Onset=[[Intravenous min onset time::1]] - [[Intravenous max onset time::2]] [[Intravenous onset time units::minutes]]
|IntravenousROA_Peak=[[Intravenous min peak time::5]] - [[Intravenous max peak time::10]] [[Intravenous peak time units::minutes]]
|IntravenousROA_Offset=
|IntravenousROA_Aftereffects=[[Intravenous min aftereffects time::1]] - [[Intravenous max aftereffects time::12]] [[Intravenous aftereffects time units::hours]]

}}

Template:SubstanceBox/Sufentanil - Revision history

Sysop: 1 revision imported

en>Isaak: Common names correctly annotated.